Drugmakers and pharmacists battle over who gets to make obesity drugs
(By Sydney Lupkin for NPR) Ozempic and similar drugs for Type 2 diabetes and weight loss are in such high
Read More(By Sydney Lupkin for NPR) Ozempic and similar drugs for Type 2 diabetes and weight loss are in such high
Read More(By Paige Twenter for Becker’s Hospital Review) The sole suppliers for a few medications, including a Parkinson’s disease therapy, are
Read More(By Paige Twenter for Becker’s Hospital Review) About two-thirds of providers recently told Premier their teams are spending more than
Read More(By Sydney Lupkin for NPR) Jim Cox had heard of people with Type 2 diabetes who were unable to get
Read More(By Paige Twenter for Becker’s Hospital Review) Multiple solutions of etoposide, an injectable used for testicular and small cell lung
Read More(By Ashleigh Hollowell for Becker’s Hospital Review) Ongoing drug shortages throughout the last year in many cases have forced healthcare
Read More(By Arthur Allen for KFF Health News) On Nov. 22, three FDA inspectors arrived at the sprawling Intas Pharmaceuticals plant
Read More(By Yuki Noguchi for NPR) Toni Dezomits is used to facing death. She served in the Gulf War and later
Read More(By Paige Twenter for Becker’s Hospital Review) The infection antibiotic amoxicillin is in short supply among at least three drugmakers,
Read More